As part of a Swedish study, a team of researchers found that patients with treatment-resistant depression could be at a higher risk of developing a substance use disorder compared to other patients
Findings from a double-blind crossover study indicated that ketamine’s acute antidepressant effect involves the activation of the brain’s opioid system.
Magnetic brain stimulation therapy lasting about three minutes significantly reduced treatment-resistant depression.